ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: Additional alterations in the BCR-ABL1 kinase domain are also possible (174–179), but in general genetic and cellular heterogeneity in chronic phase of CML is much lower than observed in AML (62).